Vaidya Sane Ayurved Laboratories Limited
ListedSMEHealthcare / Pharmaceuticals · NSE
Madhavbaug is a medical service provider specializing in the treatment of chronic ailments such as cardiac diseases, diabetes, hypertension, obesity, and knee pain, using a combination of modern technology and traditional Ayurveda practices through non-invasive, multidisciplinary therapies. As of November 30, 2021, it operates 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, and Chhattisgarh, including 52 company-owned and 222 franchise clinics, along with two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur. The company also offers wellness products online through Madhavbaug Wellness and supports patients via the MIB Pulse App.
Price Band
₹73
Issue Size
₹20.23 Cr
Lot Size
1600 shares
GMP
—
Est. Listing
₹73
at current GMP
Subscribed
—
Open
10 Feb 2022
Close
15 Feb 2022
Allotment
21 Feb 2022
Refund
22 Feb 2022
Demat Credit
23 Feb 2022
Listing
23 Feb 2022
Last updated 12 days ago
Overall Subscription
0.00x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 1,385,616 | — | 0.00x |
| Non-Institutional (NII / HNI) | 415,685 | — | 0.00x |
| Retail Individual (RII) | 969,932 | — | 0.00x |
| Total | 2,771,233 | 0 | 0.00x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 606 | 606 | 1.00x |
| HNIs (10L +) | 4 | 4 | 1.00x |
| HNIs (2-10L) | 19 | 19 | 1.00x |
| Total Applications | 629 | 629 | 1.00x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Vaidya Sane Ayurved Laboratories Limited Public Issue & Market Profile
Vaidya Sane Ayurved Laboratories Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹20.23 Crores. The shares are offered at a price band of ₹73 to ₹73 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Bidding & Quota Instructions:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Allotment Reconciliation Schedule:
Following the close of bidding on 2022-02-15, the basis of allotment is scheduled to be finalized on 2022-02-21. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Vaidya Sane Ayurved Laboratories Limited IPO GMP today?
Currently, Vaidya Sane Ayurved Laboratories Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹73 to ₹73 per equity share.
What is the expected profit per lot for Vaidya Sane Ayurved Laboratories Limited IPO?
The retail lot size is 1600 shares requiring a minimum application amount of ₹1,16,800. Expected listing price is ₹73 per equity share.
What is the issue size and price band for Vaidya Sane Ayurved Laboratories Limited IPO?
The Vaidya Sane Ayurved Laboratories Limited IPO aggregate issue size is ₹20.23 Crores with an equity price band set at ₹73 to ₹73 per equity share. The retail lot size is 1600 shares requiring a minimum capital outlay of approx. ₹1,16,800.
How can I check Vaidya Sane Ayurved Laboratories Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.
Where and when will Vaidya Sane Ayurved Laboratories Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2022-02-21. Investors can verify status using PAN card or application number.
When is the listing date for Vaidya Sane Ayurved Laboratories Limited IPO?
Vaidya Sane Ayurved Laboratories Limited shares are scheduled to list on NSE on 2022-02-23.